Clinical Trials
https://clinicaltrials.gov/ct2/show/NCT02971605
Selected Publications
View all on PubMed
Barrett FS, Preller KH, Herdener M, Janata P, Vollenweider FX (2017). Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music. Cerebral Cortex, 2017 Sep 28:1-12. doi: 10.1093/cercor/bhx257. [Epub ahead of print]
Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR (2017). Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions. Frontiers in Psychology 8, 1238
Barrett FS, Griffiths RR, Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Curr Top Behav Neurosci. 2017 Mar 26. doi: 10.1007/7854_2017_474. [Epub ahead of print]
Barrett FS, Workman CI, Sair HI, Savonenko AV, Kraut MA, Sodums DJ, Joo JJ, Nassery N, Marano CM, Munro CA, Brandt J, Zhou Y, Wong DF, Smith GS (2017). Association between serotonin denervation and resting‐state functional connectivity in mild cognitive impairment. Human Brain Mapping 38 (7), 3391-3401
Barrett FS, Johnson MW & Griffiths RR (2015). Validation of the Revised Mystical Experience Questionnaire in Experimental Sessions with Psilocybin. Journal of Psychopharmacology, 29(11):1182-90
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.